Contact hours available until 2/28/2021. Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. Authors Conflict of Interest Disclosure: The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article. Commercial Support and Sponsorship: No commercial support or sponsorship declared. Accreditation Information: This educational activity is jointly provided by Anthony J. Jannetti, Inc. and the Academy of Medical-Surgical Nurses (AMSN).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number CEP 5387. Licensees in the state of California must retain this certificate for four years after the CNE activity is completed.
This article was reviewed and formatted for contact hour credit by Michelle Boyd, MSN, RN, AMSN Education Director. Learning Outcome: After completing this learning activity, the learner will be able to identify how early recognition and treatment and close surveillance by the nurse and the inter-professional team will help the patient to achieve quality of life. Learning Engagement Activity: Review Table 2 and identify 3 nursing assessment priorities for the patient with AIH.
You must be logged in and own this product in order to post comments.
3/21/19 9:46 pm
7/29/19 1:28 pm
Early and aggressive therapy in AIH can slow or prevent the progression to cirrhosis. Patients in remission usually have a normal lifespan (Czaja, 2016).
10/7/19 4:22 pm
Patients need to be closely monitored for potential side effects of their medication they are taking to treat AIH. It's encouraging to see the statistics on lifespan with early recognition and treatment.